MX9302818A - Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina. - Google Patents
Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina.Info
- Publication number
- MX9302818A MX9302818A MX9302818A MX9302818A MX9302818A MX 9302818 A MX9302818 A MX 9302818A MX 9302818 A MX9302818 A MX 9302818A MX 9302818 A MX9302818 A MX 9302818A MX 9302818 A MX9302818 A MX 9302818A
- Authority
- MX
- Mexico
- Prior art keywords
- somatostatin
- reduction
- agent
- inhibit
- increase
- Prior art date
Links
- 102000005157 Somatostatin Human genes 0.000 title abstract 5
- 108010056088 Somatostatin Proteins 0.000 title abstract 5
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 5
- 229960000553 somatostatin Drugs 0.000 title abstract 5
- 230000028327 secretion Effects 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010030216 Oesophagitis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N carbostyril Natural products C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 1
- -1 carbostyril compound Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000006881 esophagitis Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un agente para incrementar la secreción de somatostatina o inhibir la reducción de secreción de somatostatina que comprende como un ingrediente activo un compuesto carboestirilo de la fórmula o una sal del mismo, que es útil para tratar enfermedades asociadas con la reducción de somatostatina tales como esofagitis, enfermedad de Alzheimer, etc.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12179192 | 1992-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9302818A true MX9302818A (es) | 1994-04-29 |
Family
ID=14819994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9302818A MX9302818A (es) | 1992-05-14 | 1993-05-13 | Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5476858A (es) |
| EP (1) | EP0594867A1 (es) |
| KR (1) | KR100192534B1 (es) |
| CN (1) | CN1038903C (es) |
| AU (1) | AU657412B2 (es) |
| CA (1) | CA2112262A1 (es) |
| MX (1) | MX9302818A (es) |
| TW (1) | TW227558B (es) |
| WO (1) | WO1993023043A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2138092T3 (es) * | 1993-10-21 | 2000-01-01 | Otsuka Pharma Co Ltd | Utilizacion de los derivados de carbostirilo para la obtencion de un medicamento destinado para inhibir la produccion de la interleucina-8. |
| JPH0971532A (ja) * | 1995-09-06 | 1997-03-18 | Otsuka Pharmaceut Co Ltd | 発癌抑制剤 |
| AR004214A1 (es) * | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| KR100681360B1 (ko) * | 2003-07-30 | 2007-02-12 | 오츠카 세이야쿠 가부시키가이샤 | 타액분비 촉진용 카르보스티릴 유도체 |
| TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
| EP2402465B1 (en) * | 2004-07-13 | 2014-11-19 | Gen-Probe Incorporated | Method and kit for detection of Hepatitis A virus nucleic acid |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| US4612302A (en) * | 1983-11-14 | 1986-09-16 | Brigham And Women's Hospital | Clinical use of somatostatin analogues |
| JP2812998B2 (ja) * | 1989-08-14 | 1998-10-22 | 大塚製薬 株式会社 | 胃炎治療剤 |
| JP2820739B2 (ja) * | 1989-10-28 | 1998-11-05 | 大塚製薬株式会社 | カルボスチリル誘導体の製造法 |
| EP0543018B1 (en) * | 1991-06-07 | 1996-01-10 | Otsuka Pharmaceutical Co., Ltd. | Antidiabetic agent |
-
1993
- 1993-04-21 TW TW082103045A patent/TW227558B/zh active
- 1993-04-27 WO PCT/JP1993/000545 patent/WO1993023043A1/en not_active Ceased
- 1993-04-27 KR KR1019940700021A patent/KR100192534B1/ko not_active Expired - Fee Related
- 1993-04-27 CA CA002112262A patent/CA2112262A1/en not_active Abandoned
- 1993-04-27 EP EP93909427A patent/EP0594867A1/en not_active Withdrawn
- 1993-04-27 AU AU40229/93A patent/AU657412B2/en not_active Ceased
- 1993-04-27 US US08/193,124 patent/US5476858A/en not_active Expired - Fee Related
- 1993-05-13 MX MX9302818A patent/MX9302818A/es unknown
- 1993-05-14 CN CN93106046A patent/CN1038903C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU657412B2 (en) | 1995-03-09 |
| CN1038903C (zh) | 1998-07-01 |
| TW227558B (es) | 1994-08-01 |
| AU4022993A (en) | 1993-12-13 |
| WO1993023043A1 (en) | 1993-11-25 |
| KR100192534B1 (ko) | 1999-06-15 |
| US5476858A (en) | 1995-12-19 |
| CA2112262A1 (en) | 1993-11-25 |
| CN1080851A (zh) | 1994-01-19 |
| EP0594867A1 (en) | 1994-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0444196A4 (en) | Agent for treatment and prophylaxis of ischemic disease of heart or brain | |
| PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
| ES2176600T3 (es) | Derivado de la propiofenona y procedimientos para su preparacion. | |
| MY137348A (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| ES2051700T3 (es) | Un proceso para la preparacion de un compuesto beta-lactama. | |
| RU94045155A (ru) | Способы ингибирования болезни альцгеймера | |
| GB0225475D0 (en) | Therapeutic agents | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| BR0011225A (pt) | Agente para tratar de olhos secos, seu método e uso | |
| MX9305248A (es) | Compuestos de diarilpiperazinoacetamida. | |
| EP0699439A3 (en) | Treatment of diseases caused by sebum with inhibitors of acyl CoA cholesterol acyltransferase | |
| RU94044454A (ru) | Ингибитор аутоимунных заболеваний | |
| BR0113389A (pt) | Compostos que inibem a atividade do fator xa | |
| RU94044356A (ru) | Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с | |
| ES2092646T3 (es) | Metanoantracenos como antagonistas de dopamina. | |
| EP1284265A4 (en) | BENZOTHIOPHENE DERIVATIVES AND MEDICINAL USE THEREOF | |
| AR032066A1 (es) | Agente para tratamiento terapeutico y profilactico del dolor neuropatico | |
| MX9302818A (es) | Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina. | |
| TR199701497T1 (xx) | Beyin �demini �nleyen terkip. | |
| ES2181927T3 (es) | Derivados de 1-metilcarbapenem. | |
| ES2127469T3 (es) | Composiciones dermatologicas que contienen una sal del acido lactico. | |
| ES2119130T3 (es) | Microbiocidas. | |
| SE0004101D0 (sv) | New use | |
| ES2103825T3 (es) | Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales. | |
| MY104521A (en) | Treatment of depression. |